Tommaso Paoli

Tommaso Paoli has extensive experience in the biopharmaceutical industry, particularly in the field of quality management. Tommaso began their career at Kedrion Biopharma in 2006 as a QA Plasma Release Associate and steadily progressed through various roles, including QA Statistics Responsible, Global QA Projects Coordinator, Global QA Auditing & Projects Manager, Group Plasma Quality Manager, Director of Quality Operations Melville, and Global Plasma Quality Director. From 2018 to 2019, they also served as the Director of US Quality Operations. In 2019, they were appointed as the Global Plasma Quality & Regulatory Director. Following this, they briefly held the role of Site Leader (Executive) at the Melville Plant before being promoted to their current position as Senior Vice President Global Quality, where they lead and executes the Quality strategy and goals for the entire company, including the plasma business unit. In addition to their time at Kedrion Biopharma, Tommaso also worked as the Director of Quality at KEDPLASMA from 2017 to 2018. Prior to their career in the biopharmaceutical industry, Tommaso obtained a PhD in Evolutionary Biology from the University of Pisa between 2002 and 2005. Tommaso is currently set to join BPL Plasma as the Senior VP of Global Quality in November 2022.

Tommaso Paoli obtained a Mini MBA in Business Administration and Management, General from Rutgers University in the year 2020. Prior to that, they pursued a degree in Biological Sciences at Università di Pisa from 1994 to 2001. Tommaso completed their high school education at Cavanis High School from 1989 to 1994. Moreover, Tommaso Paoli holds a Doctor of Philosophy - PhD in Biology/Biological Sciences, General from Università di Pisa.